Surgical Science Sweden Stock Current Valuation
| 0AAU Stock | 149.50 0.10 0.07% |
Valuation analysis of Surgical Science Sweden helps investors to measure Surgical Science's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Total Cash From Operating Activities is likely to gain to about 156.4 M in 2024, whereas Change In Cash is likely to drop slightly above 108.7 M in 2024. Fundamental drivers impacting Surgical Science's valuation include:
Enterprise Value 6.3 B | Trailing PE 0.6823 |
Overvalued
Today
Please note that Surgical Science's price fluctuation is very steady at this time. Calculation of the real value of Surgical Science Sweden is based on 3 months time horizon. Increasing Surgical Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Surgical stock is determined by what a typical buyer is willing to pay for full or partial control of Surgical Science Sweden. Since Surgical Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgical Stock. However, Surgical Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 149.5 | Real 140.55 | Hype 148.49 | Naive 155.44 |
The intrinsic value of Surgical Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Surgical Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Surgical Science Sweden helps investors to forecast how Surgical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgical Science more accurately as focusing exclusively on Surgical Science's fundamentals will not take into account other important factors: Surgical Science Sweden Company Current Valuation Analysis
Surgical Science's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Surgical Science Current Valuation | 6.32 B |
Most of Surgical Science's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Surgical Science Sweden has a Current Valuation of 6.32 B. This is 13.17% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The current valuation for all United Kingdom stocks is 61.96% higher than that of the company.
Surgical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgical Science's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics of similar companies.Surgical Science is currently under evaluation in current valuation category among its peers.
Surgical Fundamentals
| Return On Equity | 0.0436 | |||
| Return On Asset | 0.0195 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 6.32 B | |||
| Shares Owned By Insiders | 25.73 % | |||
| Shares Owned By Institutions | 54.70 % | |||
| Revenue | 838.25 M | |||
| Gross Profit | 531.52 M | |||
| EBITDA | 179.07 M | |||
| Net Income | 233.97 M | |||
| Book Value Per Share | 85.16 X | |||
| Earnings Per Share | 2.19 X | |||
| Number Of Employees | 265 | |||
| Beta | 0.97 | |||
| Retained Earnings | 273.79 M |
About Surgical Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgical Science Sweden's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science Sweden based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.